Apollo Therapeutics accelerates British academic research to the clinic with funding and drug discovery expertise.

Gyroscope develops gene therapies for eye diseases related to complement system imbalance. Their innovative treatments aim to improve eye health and vision.

Revolutionizing cloud hosting with the world's pioneering Kubernetes service, powered by Rancher Lab's K3s. Experience seamless, cutting-edge technology for optimized performance.

NeRRe Therapeutics develops neurokinin receptor antagonists for clinical and pre-clinical use. The company focuses on advancing treatments for neurological disorders.

Auspherix is an Australian company creating innovative antibiotics to combat drug-resistant bacterial infections. Their mission is to develop effective treatments for challenging diseases.

Stevenage Bioscience Catalyst is the UK's pioneering open innovation hub for biomedical startups. It fosters collaboration and advancement in the industry.

WallJAM is a shaped, interactive rebound wall and sports activity zone.

Revolutionizing cataract treatment with an innovative approach. Offering a streamlined process for patients to regain clear vision quickly and effectively.

Galvani Bioelectronics is named after Luigi Aloisio Galvani, an 18th century Italian scientist, physician and philosopher, who was one of the first to explore the field of bioelectricity.

Decidable develops software and online tools to translate data into words in English language. It uses artificial intelligence to interpret and explain data. Decidable was founded in 2021 and is headquartered in Hertfordshire, London.

Grafty partners with trades businesses to dominate their local market, and while doing so, we help to establish proven systems, increase your revenue, and earn back more of your valuable time.

Apollo Therapeutics accelerates British academic research to the clinic with funding and drug discovery expertise.

Gyroscope develops gene therapies for eye diseases related to complement system imbalance. Their innovative treatments aim to improve eye health and vision.

NeRRe Therapeutics develops neurokinin receptor antagonists for clinical and pre-clinical use. The company focuses on advancing treatments for neurological disorders.

Gyroscope develops gene therapies for eye diseases related to complement system imbalance. Their innovative treatments aim to improve eye health and vision.

Apollo Therapeutics accelerates British academic research to the clinic with funding and drug discovery expertise.

Revolutionizing cloud hosting with the world's pioneering Kubernetes service, powered by Rancher Lab's K3s. Experience seamless, cutting-edge technology for optimized performance.

NeRRe Therapeutics develops neurokinin receptor antagonists for clinical and pre-clinical use. The company focuses on advancing treatments for neurological disorders.

Revolutionizing cloud hosting with the world's pioneering Kubernetes service, powered by Rancher Lab's K3s. Experience seamless, cutting-edge technology for optimized performance.

Apollo Therapeutics accelerates British academic research to the clinic with funding and drug discovery expertise.

NeRRe Therapeutics develops neurokinin receptor antagonists for clinical and pre-clinical use. The company focuses on advancing treatments for neurological disorders.

Apollo Therapeutics accelerates British academic research to the clinic with funding and drug discovery expertise.

Gyroscope develops gene therapies for eye diseases related to complement system imbalance. Their innovative treatments aim to improve eye health and vision.

NeRRe Therapeutics develops neurokinin receptor antagonists for clinical and pre-clinical use. The company focuses on advancing treatments for neurological disorders.